EUROLAB
usp-1231-water-for-pharmaceutical-purposes-microbial-limits
Endotoxin & Bioburden Testing AAMI RD52 Endotoxin Limits for Dialysis FluidsAATCC TM100 Test for Antimicrobial Activity of TextilesANSI/AAMI ST72 Guidance on Bacterial Endotoxin Testing for Medical DevicesASTM D4414 Bioburden in Coated TextilesASTM D7295 Bioburden Testing on Coated Medical TextilesASTM E2314 Bioburden Testing in Medical Device ComponentsASTM E2406 Real-Time Endotoxin Detection Method ValidationASTM E2614 Bioburden in Industrial Water SystemsASTM E2883 Rapid Endotoxin Detection for Sterile PharmaceuticalsASTM F1608 Bacterial Filtration and Bioburden in Respiratory Protection DevicesASTM F1980 Bioburden Evaluation in Accelerated Aged ProductsASTM F2018 Endotoxin Testing of Contact Lens Care ProductsASTM F640 Bioburden Testing for Surgical DrapesEN 556 Sterilization of Medical Devices – Bioburden LimitsEN ISO 20857 Bioburden Control for Liquid Chemical SterilantsEP 2.6.1 Microbial Testing in Topical PreparationsEP 2.6.12 Microbial Limits Tests for Non-Sterile ProductsEP 2.6.14 Bacterial Endotoxins Test for Pharmaceutical PreparationsEP 2.6.25 Limulus Amebocyte Lysate Test Methods ValidationEP 2.6.30 Endotoxin Testing in Biotechnology ProductsEP 2.6.31 Limulus Amebocyte Lysate Test for EndotoxinsEP 5.1.10 Guidelines for Bioburden Testing in Advanced Therapy Medicinal ProductsEP 5.1.2 Biological Indicators for Sterilization Process ControlEP Monograph 04/2013:20619 Pyrogen and Endotoxin TestingFDA CBER Guidance on Endotoxin Testing of VaccinesFDA CDER Guidance on Bioburden Control in Drug ManufacturingFDA Guidance for Industry on Pyrogen and Endotoxin TestingISO 10993-1 Biological Evaluation of Medical Devices – Endotoxin AssessmentISO 10993-18 Bioburden Interaction with Extractables and LeachablesISO 11137-2 Sterilization Process Validation and Bioburden TestingISO 11138-1 Biological Indicators for Sterilization – Bioburden EvaluationISO 11139 Sterilization Terminology and Bioburden DefinitionsISO 11607 Packaging for Terminally Sterilized Medical Devices – Bioburden ConsiderationsISO 11607-2 Packaging for Terminal Sterilized Devices – Bioburden ConsiderationsISO 11731 Detection of Legionella in Water SystemsISO 11737-1 Bioburden Determination on Medical DevicesISO 11737-1 Bioburden on Reusable Surgical InstrumentsISO 11737-1 Bioburden Testing for Dental ImplantsISO 11737-2 Bioburden Testing for Sterile Barrier SystemsISO 11737-2 Sterility Assurance and Bioburden ControlISO 13408-1 Aseptic Processing Bioburden ControlISO 13408-2 Aseptic Processing Microbiological MonitoringISO 14160 Endotoxin Removal Validation for Sterile LiquidsISO 14161 Bioburden Reduction Using FiltrationISO 14161 Validation of Bioburden Testing MethodsISO 14698-1 Cleanroom Biocontamination Control and MonitoringISO 14971 Risk Management of Endotoxin Contamination in Medical DevicesISO 15883-1 Bioburden Testing for Washer-DisinfectorsISO 17665-1 Moist Heat Sterilization – Bioburden ValidationISO 18562-1 Evaluation of Bioburden in Medical Devices – Part 1ISO 18562-4 Bioburden Testing in Medical Device Gas PathwaysISO 22519 Ultrafiltration Bioburden Reduction TestingISO 29621 Microbiological Examination of CosmeticsISO 80369-1 Endotoxin Limits for Small-Bore ConnectorsISO 80369-7 Small Bore Connectors Bioburden EvaluationISPE Baseline Guide Volume 7 Bioburden Control in Biopharmaceutical ManufacturingJP 15.02 Endotoxin Limit Test for Dialysis FluidsJP 4.05 Bacterial Endotoxin Test for Parenteral DrugsJP 4.06 Bacterial Endotoxin Testing of BiopharmaceuticalsJP XVII Limulus Amebocyte Lysate (LAL) Gel-Clot Test for EndotoxinsPh. Eur. Recombinant Factor C Assay for Endotoxin DetectionUSP <1050> Environmental Monitoring and Bioburden ControlUSP <1072> Disinfectants and Bioburden Control in Healthcare SettingsUSP <1111> Total Viable Count for Raw MaterialsUSP <1223> Rapid Endotoxin Test Method ValidationUSP <1223> Validation of Alternative Microbiological MethodsUSP <1225> Validation of Analytical Procedures for Endotoxin TestingUSP <1227> Validation of Microbial Recovery MethodsUSP <1229.10> Bioburden Testing in Steam SterilizationUSP <1229.12> Endotoxin Risk Assessment in Sterile ManufacturingUSP <1229.4> Microbial Testing for Aseptic Manufacturing EnvironmentsUSP <1229.9> Bioburden Validation in Isolator TechnologyUSP <1231> Bioburden Limits in Purified Water SystemsUSP <1232> Elemental Impurities and Bioburden ImpactUSP <61> Microbial Enumeration Test for Sterile ProductsUSP <61> Microbial Load Test for Oral Dosage FormsUSP <62> Test for Specified Microorganisms in Non-Sterile ProductsUSP <71> Sterility Testing for Ophthalmic ProductsUSP <800> Bioburden Control in Hazardous Drug CompoundingUSP <85> Bacterial Endotoxin Test for Injectable Pharmaceutical ProductsWHO TRS 1003 Endotoxin Testing Validation for Parenteral Products

USP <1231> Water for Pharmaceutical Purposes Microbial Limits Laboratory Testing Service: A Comprehensive Guide

The USP <1231> Water for Pharmaceutical Purposes Microbial Limits laboratory testing service provided by Eurolab is governed by various international and national standards. These standards ensure that the testing procedures are reliable, accurate, and compliant with regulatory requirements.

  • ISO 17025:2017 - General Requirements for the Competence of Testing and Calibration Laboratories

  • ASTM E1174-18 - Standard Practice for Determination of Microbial Limits of Waters Intended for Injection

  • EN 12223-1:2008 - Water quality Detection and determination of microbiological parameters Part 1: General guidance on methods

  • TSE 2162 - Turkish Standards Institution, Water Quality Microbiological Limits

    • The legal and regulatory framework surrounding this testing service is governed by various international and national regulations. These include:

  • USP <1231> - Water for Pharmaceutical Purposes, Microbial Limits

  • EudraLex Volume 4, Annex I - Good Manufacturing Practice (GMP) guidelines for pharmaceuticals in the European Union

  • 21 CFR Part 111 - Current Good Manufacturing Practice (CGMP) in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements

    • Standard development organizations play a crucial role in updating and revising standards to reflect advances in technology and changing regulatory requirements. These organizations include:

  • International Organization for Standardization (ISO)

  • American Society for Testing and Materials (ASTM)

  • European Committee for Standardization (CEN)

    • Standards evolve through a continuous process of revision and update. This ensures that the testing procedures remain current and compliant with regulatory requirements.

    The USP <1231> Water for Pharmaceutical Purposes Microbial Limits laboratory testing service is required to ensure the safety and efficacy of pharmaceutical products. The consequences of not performing this test can include:

  • Product contamination: Failure to detect microbial contaminants can lead to product recalls, loss of customer confidence, and financial losses.

  • Regulatory non-compliance: Non-compliance with regulatory requirements can result in fines, penalties, and reputational damage.

    • The industries that require this testing service include:

  • Pharmaceutical manufacturers

  • Biotechnology companies

  • Medical device manufacturers

    • The risk factors associated with not performing this test include:

  • Product contamination

  • Regulatory non-compliance

  • Customer dissatisfaction

    • Quality assurance and quality control aspects are critical to ensuring the accuracy and reliability of testing results. These include:

  • Calibration and validation of equipment

  • Sample preparation and handling procedures

  • Testing parameters and conditions

    • This test contributes to product safety and reliability by detecting microbial contaminants that can compromise product quality.

    The competitive advantages of having this testing performed include:

  • Improved product safety

  • Enhanced customer confidence

  • Increased regulatory compliance

    • The USP <1231> Water for Pharmaceutical Purposes Microbial Limits laboratory testing service is conducted using the following equipment and instruments:

  • Autoclaves for sterilization

  • Incubators for microbial growth

  • Microscopes for sample examination

    • The testing environment requirements include:

  • Temperature control: 20-25C (68-77F)

  • Humidity control: 50-60 relative humidity

  • Pressure control: atmospheric pressure

    • Sample preparation procedures involve:

  • Sampling from production equipment

  • Homogenization and filtration

    • The testing parameters and conditions include:

  • Microbial enumeration using plate count techniques

  • Microbial identification using biochemical tests

    • Measurement and analysis methods include:

  • Visual examination of samples for microbial growth

  • Microbiological assays to detect microbial contaminants

    • Calibration and validation procedures involve:

  • Equipment calibration

  • Method validation

    • Quality control measures during testing include:

  • Sampling and preparation protocols

  • Testing parameters and conditions

    • Data collection and recording procedures involve:

  • Documentation of testing results

  • Maintenance of laboratory records

    • The test results are documented and reported in a standard format. This includes:

  • Test report format: Eurolabs standard reporting template

  • Interpretation of test results: Explanation of testing parameters and conditions

  • Certification and accreditation aspects: Details of laboratory certification and accreditation

    • Reporting standards and formats include:

  • Eurolabs standard reporting template

  • Regulatory requirements for reporting

    • Conclusion

    The USP <1231> Water for Pharmaceutical Purposes Microbial Limits laboratory testing service provided by Eurolab is governed by various international and national standards. The testing procedure involves equipment calibration, sample preparation, and microbiological assays to detect microbial contaminants. Quality assurance and quality control aspects are critical to ensuring the accuracy and reliability of testing results. This test contributes to product safety and reliability by detecting microbial contaminants that can compromise product quality.

    Recommendations

  • Regular calibration and maintenance of equipment

  • Compliance with regulatory requirements

  • Documentation of testing results

    • By following these recommendations, pharmaceutical manufacturers, biotechnology companies, and medical device manufacturers can ensure the accuracy and reliability of their products.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers